Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Grinius, Aurėja
DOB: 01-AUG-1943 (Age: 82)
Gender: female
ID: 4402-486299-5 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 17-JUL-2025

Problem list

Condition Onset Date Status
Chronic kidney disease stage 3 11-Jul-2019 active
Proteinuria due to type 2 diabetes mellitus 11-Jul-2019 active
Alzheimer's disease 28-Sep-2017 active
Chronic kidney disease stage 2 05-Jan-2017 active
Microalbuminuria due to type 2 diabetes mellitus 05-Jan-2017 active
Disorder of kidney due to diabetes mellitus 26-Jul-2012 active
Chronic kidney disease stage 1 26-Jul-2012 active
Osteoporosis 24-May-2001 active
Ischemic heart disease 25-Apr-1996 active
Chronic sinusitis 11-May-1987 active
Essential hypertension 11-Sep-1958 active

Medication list

No known medications

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 23-Jan-2025
Clostridium tetani toxoid antigen adsorbed only vaccine product 12-Aug-2021
SARS-CoV-2 mRNA vaccine 11-Mar-2021

Procedure History list

Procedure Date Reason
Notifications 24-Jul-2025 -
Certification procedure 24-Jul-2025 -
Initial patient assessment 24-Jul-2025 -
Development of individualized plan of care 24-Jul-2025 -
Hospice care 24-Jul-2025 -
Depression screening 17-Jul-2025 -
Assessment of health and social care needs 17-Jul-2025 -
Assessment of anxiety 17-Jul-2025 -
Assessment using Morse Fall Scale 17-Jul-2025 -
Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) 17-Jul-2025 -
Assessment of substance use 17-Jul-2025 -
Depression screening using Patient Health Questionnaire Two-Item score (procedure) 17-Jul-2025 -
Medication reconciliation 19-Jun-2025 -
Screening for drug abuse 19-Jun-2025 -
Screening for domestic abuse 19-Jun-2025 -
Depression screening using PHQ-9 (Patient Health Questionnaire 9) score 23-Jan-2025 -
Patient discharge 10-Aug-2015 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Dementia management 28-Sep-2017 Alzheimer's disease (disorder)
  • Patient will maintain orientation to person and place as much as possible.
  • Patient will retain ability to perform basic activities of daily living with minimal assistance.
  • Reduce frequency and severity of behavioral and psychological symptoms of dementia.
  • Patient or caregiver will administer dementia medications as prescribed at least 90% of the time.
  • Caregiver will report adequate support and resources to manage patient’s dementia care needs.
Lifestyle education regarding hypertension 11-Sep-1958 Essential hypertension (disorder)
  • Patient will receive education on lifestyle modifications to help manage blood pressure, including dietary changes, physical activity, and medication adherence.
  • Achieve and maintain systolic blood pressure within recommended range.
  • Achieve and maintain diastolic blood pressure within recommended range.
Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 01-Oct-2025 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-07-17 2025-06-19
Body Height 162.7 cm 162.7 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} 1 {score}
Body Weight 73.3 kg 73.3 kg
Body mass index (BMI) [Ratio] 27.7 kg/m2 27.7 kg/m2
Diastolic Blood Pressure 50 mm[Hg] 51 mm[Hg]
Systolic Blood Pressure 92 mm[Hg] 99 mm[Hg]
Heart rate 91 /min 92 /min
Respiratory rate 16 /min 13 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 17-JUL-2025 Reference Range Unit
Glucose [Mass/volume] in Serum or Plasma 79.3 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 12.8 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 1.9 H 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Serum or Plasma 9.8 8.5 - 10.4 mg/dL
Sodium [Moles/volume] in Serum or Plasma 136.0 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 5.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Serum or Plasma 109.3 H 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 21.5 L 22 - 32 mmol/L
Appearance of Urine Cloudy urine
Odor of Urine Urine smell ammoniacal
Clarity of Urine Translucent
Color of Urine Brown color
Glucose [Mass/volume] in Urine by Test strip 1.8 H 0 - 0.8 mg/dL
Glucose [Presence] in Urine by Test strip ++
Bilirubin.total [Mass/volume] in Urine by Test strip 1.3 H 0 - 1 mg/dL
Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine
Ketones [Mass/volume] in Urine by Test strip 16.9 H 0 - 0.5 mg/dL
Ketones [Presence] in Urine by Test strip Urine ketone test = ++
Specific gravity of Urine by Test strip 1.0 L 1.01 - 1.03 {nominal}
pH of Urine by Test strip 5.1 4.5 - 7.5 pH
Protein [Mass/volume] in Urine by Test strip 278.1 H 30 - 15 mg/dL
Protein [Presence] in Urine by Test strip Urine protein test = ++
Nitrite [Presence] in Urine by Test strip Urine nitrite negative
Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative
Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative

Device Use

Device Date (since)
Hospital bed 24-Jul-2025
Home nebulizer (physical object) 11-May-1987